Navigation Links
Cambrex Reports Third Quarter 2010 Results
Date:11/3/2010

EAST RUTHERFORD, N.J., Nov. 3, 2010 /PRNewswire-FirstCall/ -- Cambrex Corporation (NYSE: CBM) reports third quarter results for the period ended September 30, 2010.

Highlights

  • Reported sales decreased by 14.6%, and excluding the impact of foreign currency, sales decreased 11.5% compared to third quarter 2009.  
  • Adjusted EBITDA was $8.5 million in the third quarter 2010 compared to $11.0 million in the same quarter last year.
  • Debt, net of cash was $71.4 million at the end of third quarter 2010, a decrease of $5.5 million during the quarter including a positive $2.5 million impact of currency on foreign cash balances.
  • Acquired a 51% stake in Zenara Pharma, a Hyderabad, India based pharmaceutical company focused on the formulation of final dosage form products, for $20 million on November 2, 2010.
  • Narrowed the range of 2010 full year guidance for sales, excluding the impact of foreign currency, to a decline of between 3% and 5%, and Adjusted EBITDA to $41 to $44 million.

  • Basis of ReportingThe Company has provided a reconciliation from adjusted amounts to GAAP amounts at the end of this press release.  Management believes that the adjusted amounts provide a more meaningful representation of the Company's operating results for the periods presented due to the magnitude and nature of certain expenses recorded.

    Third Quarter 2010 Operating Results – Continuing OperationsThird quarter 2010 sales of $49.4 million were 14.6% lower than the third quarter 2009.  Excluding a 3.1% unfavorable impact of foreign exchange, reflecting a stronger U.S. dollar, sales decreased 11.5%.  The decrease is primarily due to the timing of orders for certain products, the effects of a supply chain disruption at a customer's facility, a negotiated contract extension for certain drug deliver
    '/>"/>

    SOURCE Cambrex Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. Cambrex Reports Third Quarter 2008 Results
    2. Cambrex Receives Notice Regarding NYSE Listing
    3. Cambrex Reports First Quarter 2009 Results
    4. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award
    5. Cambrex Reports Fourth Quarter and Full Year 2009 Results
    6. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
    7. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
    8. Par Pharmaceutical Reports Second Quarter 2008 Results
    9. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
    10. Pharmos Corporation Reports 2008 Second Quarter Results
    11. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/27/2015)... CAMBRIDGE, Mass. , Feb. 27, 2015 /PRNewswire-USNewswire/ ... Analysis of the NCATS rare-diseases portfolio " in ... of a new financing technique to reduce the ... new diseases and potentially unlock new levels of ... The product of a unique collaboration between ...
    (Date:2/27/2015)... 2015 Bionomics Limited (ASX:BNO, ADR:BMICY) is to ... BNC105 in patients with metastatic renal cancer at the ... . The data will be presented by Dr. ... Comprehensive Cancer Center in California ... data identifies Ferritin and IL-8 as two baseline biomarkers ...
    (Date:2/27/2015)...  Steep Hill, the industry leader in cannabis testing ... open a full service medical cannabis quality assurance laboratory ... advanced scientific tools and methodology to the state, for ... currently the only laboratory licensed by the New Mexico ... in order to meet the recently adopted regulatory requirements ...
    (Date:2/26/2015)... , Feb. 26, 2015  23andMe, the leading personal ... Black as Privacy Officer and Corporate Counsel. Black ... privacy laws as well as health care regulations. As ... will be responsible for reviewing, updating and enhancing the ... U.S. and abroad. She joined the company January 5, ...
    Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 223andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2
    ... researchers have developed new technology capable of removing ... efforts following nuclear disasters. The innovation could ... up millions of tonnes of water contaminated by ... waste. Professor Huai-Yong Zhu from QUT Chemistry ...
    ... DIEGO, Nov. 2, 2011 Cadence Pharmaceuticals, Inc. (NASDAQ: ... in-licensing, developing and commercializing proprietary products principally for use ... President and CEO Ted Schroeder will present the company,s ... Mountain Time (3:30pm Eastern Time) during the Credit Suisse ...
    ... Axia Value Chain, a market leader in business transformation ... their Life Sciences and Health Care Practice Group. In ... global clients in the Health Care and Life Science ... practice development, and service offerings concentrating on alignment of ...
    Cached Biology Technology:Technology makes storing radioactive waste safer 2Axia Value Chain Appoints John Christina Managing Director of Life Sciences Practice 2
    (Date:2/5/2015)... PARK, North Carolina , 5. Februar ... 35. Jahr als spezialisiertes Logistikunternehmen und hat ... als einzige klinische Logistikfirma (Clinical Logistics Organization ... Kernbotschaft der neuen Kampagne lautet First ... Lieferungen. Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
    (Date:2/5/2015)... Conn. , Jan. 26, 2015 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... new corporate website ( http://www.nxt-id.com/ ) as part of ... smart wallet. The Company launched its new consumer website ... Gino Pereira , CEO of NXT-ID said, "Our new ...
    (Date:2/5/2015)... Conn. , Jan. 28, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... at the upcoming RedChip Global Online CEO Conference on ... Gino Pereira , CEO of NXT-ID ... its lead product, the Wocket smart wallet and its ...
    Breaking Biology News(10 mins):Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
    ... , NEW YORK (February 24, 2012) A new ... Society, and others uses a new scientific methodology for ... "diversified portfolio" of management options from strict no-take ... methodology looks at existing information on the country,s climate, ...
    ... -- Neither births nor deaths stop the flocking of organisms. ... of the University of Oregon. The notion, he says, has ... therapies. Picture any scenario in which self-propelled organisms -- ... even tiny plastic rods on a vibrating table -- move ...
    ... saved an iconic Australian lizard species from death at the ... the March issue of The American Naturalist . It,s ... for the arrival of another, says Richard Shine, a biologist ... Cane toads were introduced in Australia in the ...
    Cached Biology News:Study IDs new marine protected areas in Madagascar 2New theory shows that neither birth nor death stops a flock 2New theory shows that neither birth nor death stops a flock 3Invasive plant protects Australian lizards from invasive toad: Study 2
    ... specificity and signaling of the members of ... modified by alternative splicing--which has important implications ... can perform a classical expression profiling and ... alternatively spliced forms of the gene that ...
    ... Alternative Splicing plays an important role in ... apoptosis and cell death. Splice variants have ... and inhibition of defined apoptotic pathways. With ... can perform a classical expression profiling and ...
    ... Workstation is a modular, highly scalable, automated ... 1ml or 3ml industry standard SPE cartridges, ... samples in less than two hours unattended. ... cartridges, and up to 10 modules can ...
    ... evolutionarily conserved form of cell suicide, which ... central component of this process is a ... These enzymes participate in a series of ... pro-apoptotic signals and result in the cleavage ...
    Biology Products: